These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6131385)

  • 61. Protection of ischemic myocardium during or after convalescence from acute myocardial infarction.
    Russell RO
    Chest; 1984 Feb; 85(2):248-52. PubMed ID: 6141039
    [No Abstract]   [Full Text] [Related]  

  • 62. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
    De Caterina R; Gianetti J; Simonetti I; Gensini G
    G Ital Cardiol; 1996 Nov; 26(11):1309-21. PubMed ID: 9036028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Beta blockers in secondary prevention following acute heart infarct].
    Kaufmann U
    Praxis (Bern 1994); 1995 Mar; 84(11):299-303. PubMed ID: 7724945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [After a heart infarct].
    Dunning AJ
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):683-4. PubMed ID: 6134241
    [No Abstract]   [Full Text] [Related]  

  • 67. [Long-term drug prevention of cardiovascular diseases (methodological aspects)].
    Metelitsa VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):103-7. PubMed ID: 6139116
    [No Abstract]   [Full Text] [Related]  

  • 68. Management of non-ST-Segment Elevation Myocardial Infarction.
    Van Horn SE; Maniu CV
    Med Clin North Am; 2007 Jul; 91(4):683-700; xi. PubMed ID: 17640542
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 70. Conduction disturbances and paroxysmal atrial fibrillation during acute inferior myocardial infarction.
    Patanè S; Marte F; Di Bella G; Chiribiri A
    Int J Cardiol; 2008 Sep; 129(2):e37-40. PubMed ID: 17689738
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Secondary prevention of myocardial infarction: an uncertain feeling.
    Hart JT; Barley SL
    J R Coll Gen Pract; 1982 Nov; 32(244):651-3. PubMed ID: 6130149
    [No Abstract]   [Full Text] [Related]  

  • 72. [Long-term medicinal prevention in patients who have suffered myocardial infarction].
    Doĭchinov A; Buchvarova B
    Vutr Boles; 1974; 13(5):24-9. PubMed ID: 4467458
    [No Abstract]   [Full Text] [Related]  

  • 73. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
    Stetsenko AE; Kassil' VL; Ushakova TI
    Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Drug treatment following an infarction].
    Lasserre B; Périat M
    Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
    [No Abstract]   [Full Text] [Related]  

  • 75. [Secondary prevention of acute coronary syndrome].
    Motomiya T
    J Cardiol; 1999 Mar; 33 Suppl 1():39-43. PubMed ID: 10342135
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Round-table discussion "Drug prophylaxis of heart infarct"].
    Krayenbühl HP
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1188-9. PubMed ID: 2877484
    [No Abstract]   [Full Text] [Related]  

  • 77. Management of postmyocardial infarction in the elderly patient.
    Forman R; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Anticoagulants and thrombocyte aggregation inhibitors in cerebrovascular disorders].
    Soyka D
    Med Welt; 1980 Oct; 31(40):1417-21. PubMed ID: 7464496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.